Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease
Clinical trial NCT00356408 · COMPLETED
Trial details
- NCT number
- NCT00356408
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2010-02-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.